UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms
Archives of oral biology, ISSN 0003-9969, 2011, Volume 56, Issue 7, pp. 650 - 654
Advanced Basic Science | Dentistry | Medium-chain | Antimicrobial activity | Long-chain fatty acids | Bacterial ecology | Short-chain | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Fatty Acids, Volatile - pharmacology | Propionates - pharmacology | Palmitic Acid - pharmacology | Anti-Infective Agents - pharmacology | Caproates - pharmacology | Humans | Caprylates - pharmacology | Fusobacterium nucleatum - drug effects | Lauric Acids - pharmacology | Candida albicans - drug effects | Streptococcus sanguis - drug effects | Pentanoic Acids - pharmacology | Butyric Acid - pharmacology | Streptococcus gordonii - drug effects | Aggregatibacter actinomycetemcomitans - drug effects | Biofilms - drug effects | Myristic Acid - pharmacology | Decanoic Acids - pharmacology | Acetic Acid - pharmacology | Isobutyrates - pharmacology | Materials Testing | Streptococcus mutans - drug effects | Microbial Interactions - drug effects | Mouth - microbiology | Formates - pharmacology | Fatty Acids - pharmacology | Porphyromonas gingivalis - drug effects | Lauric acid | Propionic acid | Data processing | Palmitic acid | Fatty acids | Butyric acid | Oral cavity | octanoic acid | Microorganisms | Biofilms | Formic acid | Antibacterial activity | Evolution | Acetic acid | Index Medicus
Journal Article
Applied biochemistry and biotechnology, ISSN 0273-2289, 05/2017, Volume 182, Issue 1, pp. 67 - 81
Docosapentaenoic acid / docosahexaenoic acid ratio | Schizochytrium | Docosapentaenoic acid | Docosapentaenoic acid biosynthesis | Polyunsaturated fatty acid synthase | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Propionates - pharmacology | Propionates - metabolism | Transcription, Genetic - drug effects | Heptanoic Acids - metabolism | Fatty Acid Synthases - metabolism | Caproates - pharmacology | Iodoacetamide - pharmacology | Stramenopiles - drug effects | Caprylates - pharmacology | Caprylates - metabolism | Fatty Acids, Unsaturated - biosynthesis | Stramenopiles - growth & development | Butyric Acid - metabolism | Pentanoic Acids - pharmacology | Butyric Acid - pharmacology | Pentanoic Acids - metabolism | Caproates - metabolism | Stramenopiles - genetics | Docosahexaenoic Acids - biosynthesis | Fatty Acid Synthases - genetics | Stramenopiles - enzymology | Heptanoic Acids - pharmacology | Fatty Acids - biosynthesis | Unsaturated fatty acids | Synthesis | Laws, regulations and rules | Analysis | Saturated fatty acids | Fatty acids | Omega-3 fatty acids | Transcription | Incubation | Polyunsaturated fatty acids | Propionic acid | Lipids | Oxidation | Docosahexaenoic acid | Hexanoic acid | Octanoic acid | Butyric acid | Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 05/2017, Volume 7, Issue 1, pp. 2360 - 12
PROPIONATE | OXIDATION | GLUCAGON-LIKE PEPTIDE-1 | FOOD-INTAKE | ULCERATIVE-COLITIS | OLETF RATS | HUMANS | ACETATE | INSULIN SENSITIVITY | ADIPOSE-TISSUE | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Fatty Acids, Volatile - pharmacology | Propionates - pharmacology | Fasting | Double-Blind Method | Humans | Colon - drug effects | Acetic Acid - administration & dosage | Fats - metabolism | Infusions, Parenteral | Acetic Acid - pharmacology | Butyric Acid - administration & dosage | Male | Propionates - administration & dosage | Obesity - metabolism | Cross-Over Studies | Overweight - metabolism | Fatty Acids, Volatile - administration & dosage | Oxidation-Reduction - drug effects | Postprandial Period | Adult | Butyric Acid - pharmacology | Energy Metabolism - drug effects | Obesity | Energy metabolism | Propionic acid | Diabetes mellitus | Body weight | Glycerol | Energy expenditure | Metabolism | Fermentation | Fatty acids | Insulin | Lipolysis | Studies | Calorimetry | Oxidation | Dietary fiber | Acetic acid | Index Medicus
Journal Article
European journal of pharmacology, ISSN 0014-2999, 08/2016, Volume 785, pp. 50 - 58
Inflammation | Unsaturared fatty acid | Cell function | Neutrophil | Saturated fatty acid | Short chain fatty acids | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cell Survival - drug effects | Neutrophils - cytology | Animals | Fatty Acids - chemistry | Humans | Neutrophils - drug effects | Neutrophils - immunology | Neutrophil Infiltration - drug effects | Fatty Acids - pharmacology | Physiological aspects | Unsaturated fatty acids | Lymphocytes | Cell death | Saturated fatty acids | Index Medicus
Journal Article
Oncology reports, ISSN 1021-335X, 02/2014, Volume 31, Issue 2, pp. 955 - 968
Zoledronic acid | Sodium butyrate | Chemotherapy | Ewing sarcoma | Synergistic effect | Adjuvant therapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Tumor Stem Cell Assay | Vincristine - pharmacology | Antibiotics, Antineoplastic - pharmacology | Humans | Etoposide - pharmacology | Imidazoles - pharmacology | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Bone Density Conservation Agents - pharmacology | Sarcoma, Ewing - drug therapy | Drug Synergism | Cell Line, Tumor | Histamine Antagonists - pharmacology | Histone Deacetylase Inhibitors - pharmacology | Butyric Acid - pharmacology | Cell Proliferation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Diphosphonates - pharmacology | Doxorubicin - pharmacology
Journal Article
Pharmacology, biochemistry and behavior, ISSN 0091-3057, 11/2014, Volume 126, pp. 43 - 49
Autism spectrum disorders | Sodium butyrate | Histone deacetylase | Dendritic spines | Valproic acid | Hippocampus | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology | Autistic Disorder - chemically induced | Autistic Disorder - pathology | CA1 Region, Hippocampal - cytology | Prenatal Exposure Delayed Effects - prevention & control | Male | Valproic Acid - pharmacology | CA1 Region, Hippocampal - drug effects | Butyric Acid - therapeutic use | Dendritic Spines - drug effects | Exploratory Behavior - drug effects | CA1 Region, Hippocampal - metabolism | Female | Valproic Acid - therapeutic use | Butyric Acid - pharmacology | Acetylation | Valproic Acid - adverse effects | Disease Models, Animal | Butyric Acid - administration & dosage | Autistic Disorder - psychology | Pregnancy | Animals | Valproic Acid - administration & dosage | Dendritic Spines - pathology | Histone Deacetylase Inhibitors - pharmacology | Mice | Histones - metabolism | Autistic Disorder - drug therapy | Histone Deacetylase Inhibitors - adverse effects | Prenatal Exposure Delayed Effects - chemically induced | Autism | Divalproex | Esters | Social aspects | Pregnant women | Index Medicus
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 10/2019, Volume 24, Issue 20, p. 3770
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Glycerides - chemistry | Formates - chemistry | Gram-Positive Bacteria - drug effects | Monoglycerides - pharmacology | Butyric Acid - chemistry | Laurates - chemistry | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Glycerides - pharmacology | Gram-Positive Bacteria - classification | Anti-Bacterial Agents - chemistry | Formates - pharmacology | Pentanoic Acids - chemistry | Pentanoic Acids - pharmacology | Laurates - pharmacology | Anti-Bacterial Agents - pharmacology | Butyric Acid - pharmacology | Molecular Structure | Monoglycerides - chemistry | Gram-Negative Bacteria - classification | Salmonella | Antimicrobial activity | Calcium | Gram-positive bacteria | Antimicrobial agents | Derivatives | Fatty acids | Antiinfectives and antibacterials | Animal feed | Esterification | Organic acids | Osmotic stress | Streptococcus infections | Animals | Sodium | Antibiotics | E coli | Bacteria | Biomolecules | Livestock | Disruption | Feeds | Drug dosages | Campylobacter | Index Medicus | gram-positive bacteria | gram-negative bacteria | antimicrobial effects | organic acids | minimum inhibitory concentration
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2017, Volume 121, pp. 100 - 110
Thalamus | Thalamic reticular nucleus | Astrocyte | Synaptic inhibition | Metabotropic glutamate receptor subtype 2 | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals, Newborn | Astrocytes - drug effects | Calcium - metabolism | Valine - analogs & derivatives | Enzyme Inhibitors - pharmacology | Rats | Male | Sodium Channel Blockers - pharmacology | Rats, Sprague-Dawley | N-Methylaspartate - pharmacology | Dose-Response Relationship, Drug | Iontophoresis | Astrocytes - physiology | Citrates - pharmacology | Animals | Sensory Receptor Cells - physiology | Vibrissae - physiology | Excitatory Amino Acid Agents - pharmacology | Thalamus - cytology | Tetrodotoxin - pharmacology | Valine - pharmacology | In Vitro Techniques | Neurons | GABA | Glutamate | Index Medicus | VB, ventrobasal thalamus | NaCl, sodium chloride | LY487379, 2,2,2-Trifluoro-N-[4-(2-methoxyphenoxy)phenyl]-N-(3-pyridinylmethyl)ethanesulfonamide hydrochloride | mGlu3, metabotropic glutamate receptor subtype 3 | AMPA, α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | mIPSC, miniature inhibitory post-synaptic current | GABA, gamma amino butyric acid | TTX, tetrodotoxin | mGlu2, metabotropic glutamate receptor subtype 2 | PAM, positive allosteric modulator | DL-APV, DL-2-Amino-5-phosphonopentanoic acid | SEM, standard error of the mean | mGlu, metabotropic glutamate | LY341495, (2S)-2-Amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl)propanoic acid | TRN, thalamic reticular nucleus | NIH, National Institutes of Health | PSTH, post-stimulus time histogram | LY354740, (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid | SR101, Sulforhodamine 101 | i.p., intraperitoneal | ROI, region of interest | CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione | DMSO, dimethyl sulfoxide | NMDA, N-methly-d-aspartate
Journal Article
Bioresource technology, ISSN 0960-8524, 02/2014, Volume 153, pp. 206 - 215
Cupriavidus necator | Volatile fatty acids (VFA) | Phosphorus limitation | Propionic acid | Polyhydroxybutyrate-co-hydroxyvalerate P(3HB-co-3HV) | Agricultural Engineering | Life Sciences & Biomedicine | Technology | Agriculture | Biotechnology & Applied Microbiology | Energy & Fuels | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Batch Cell Culture Techniques | Oxygen - pharmacology | Propionates - metabolism | Cupriavidus necator - drug effects | Cupriavidus necator - metabolism | Fatty Acids, Volatile - metabolism | Phosphorus - pharmacology | Butyric Acid - metabolism | 3-Hydroxybutyric Acid - metabolism | Computer Simulation | Cupriavidus necator - growth & development | Nitrogen - pharmacology | Pentanoic Acids - metabolism | Metabolic Networks and Pathways - drug effects | Carbon - pharmacology | Index Medicus | Strategy | Phosphorus | Carbon | Monomers | Culture | Constraining | Butyric acid | Life Sciences
Journal Article